Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-13

Clinical Trial Update: Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Biphozyl and Phoxilium as replacement fluids during CRRT in adults with acute kidney injury, assessing effects on pH, bicarbonate levels…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biphozyl (null)
  • Phoxilium (null)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Critically Ill, Acute Kidney Injury | Phase 2 | Status: COMPLETED